Moreover, there have been many studies on GSK3B inhibitors, including Metavert molecule in PAAD (Edderkaoui et al., 2018), BT-000775 molecule in BRCA (Ogunleye et al., 2019), BIO molecule in TNBCs (triple-negative breast cancers) (Vijay et al., 2019), AR-A014418 and SB-216763 molecules in STSs (soft tissue sarcomas) (Abe et al., 2020), etc. The gene discussed is GSK3B; the disease is triple-negative breast carcinoma.